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ABSTRACT 
Identifying transcription factor (TF) binding to noncoding variants, uncharacterized DNA 
motifs, and repetitive genomic elements has been difficult due to technical and 
computational challenges. Indeed, current experimental methods such as chromatin 
immunoprecipitation are capable of only testing one TF at a time and motif prediction 
algorithms often lead to false positive and false negative predictions. Here, we address 
these limitations by developing two approaches based on enhanced yeast one-hybrid 
assays. The first approach allows to interrogate the binding of >1,000 human TFs to 
single nucleotide variant alleles, short insertions and deletions (indels), and novel DNA 
motifs; while the second approach allows for the identification of TFs that bind to 
repetitive DNA elements. Using the former approach, we identified gain of TF 
interactions to a GG AA mutation in the TERT promoter and an 18 bp indel in the 
TAL1 super-enhancer, both of which are associated with cancer, and identified the TFs 
that bind to three uncharacterized DNA motifs identified by the ENCODE Project in 
footprinting assays. Using the latter approach, we detected the binding of 75 TFs to the 
highly repetitive Alu elements. We anticipate that these approaches will expand our 
capabilities to study genetic variation and under-characterized genomic regions. 
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INTRODUCTION 
The study of transcription factor (TF) binding to different genomic regions, and how this 
binding is affected by noncoding variants, is critical to understand the mechanisms by 
which gene expression is controlled in normal and pathogenic conditions (1). 
Chromatin-immunoprecipitation followed by next-generation sequencing (ChIP-seq) has 
been instrumental in identifying the genomic regions occupied by a TF and studying TF 
function (2,3). However, it has been challenging to employ ChIP-seq to address many 
central human functional genomics problems such as determining whether disease-
associated single nucleotide variants (SNVs) and short insertions/deletions (indels) in 
noncoding regions alter TF binding, as well as identifying the TFs that bind to specific 
DNA motifs and repetitive genomic DNA elements. 
 Experimentally determining whether TF binding is altered by genomic variants 
associated with genetic diseases or cancer has been challenging as this cannot be 
performed using ChIP-seq without a priori TF candidates. This is because all ~1,500 
human TFs would have to be evaluated individually, and because samples from the 
appropriate tissues and conditions from healthy and sick individuals need to be obtained 
(1,4). Thus, the most widely used approach to prioritize TFs consists of using known 
DNA binding specificities (available for ~50% of human TFs) and motif search 
algorithms such as FIMO, BEEML-PWM or TFM-pvalue to compare predicted TF 
binding between the different noncoding alleles (5-9). However, this approach often 
results in multiple false positive and false negative predictions given that: 1) DNA motifs 
are missing for nearly half of the known human TFs, 2) it is estimated that only ~1% of 
the predicted DNA motifs in the genome are actually occupied by the TF in vivo, 3) 
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multiple genomic regions occupied by TFs do not contain the corresponding TF binding 
sites, and 4) sequence preferences for naked DNA may be different than for 
nucleosomal DNA (5,10-12). 
Many genomic regions identified by DNase I or ATAC-seq footprinting studies 
are occupied by unidentified proteins, in many cases in a sequence specific manner 
(13,14). Indeed, using genome-wide DNase I footprinting, the ENCODE Project 
identified 683 de novo motifs, 289 of which could not be matched to any TF based on 
known DNA binding specificities (13). Due to the lack of TF candidates, it is nearly 
impossible to use ChIP to identify the TFs interacting with these genomic sites, as 
hundreds of TFs would need to be tested in each of the cell lines where the footprints 
were found. Thus, to this day, most of the novel DNA motifs derived from DNase I 
footprinting remain orphan. 
More than half of the human genome is comprised of tandem or interspaced 
repetitive DNA elements, many located within promoter, enhancer, and silencer 
sequences (15). TF binding to these repetitive genomic elements is challenging to study 
by ChIP-seq, not only because hundreds of TFs need to be assayed, but also because 
repetitive DNA sequences are difficult to map to the reference genome and are thus 
often filtered out in most bioinformatics analysis pipelines (16,17). This is particularly 
true for highly repetitive elements such as the Alu short interspaced nuclear elements, 
which are present in more than one million copies in the human genome (18).  
Enhanced yeast one-hybrid (eY1H) assays provide a complementary approach 
to ChIP-seq, where physical interactions between TFs and DNA regions are tested in 
the milieu of the yeast nucleus using reporter genes (19,20). eY1H assays involve two 
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components: a ‘DNA-bait’ (e.g., a genomic variant, a novel DNA motif, or a repetitive 
element) and a ‘TF-prey’. DNA-baits are cloned upstream of two reporter genes (HIS3 
and LacZ) and integrated into the yeast genome. The DNA-bait yeast strains are then 
mated with strains that express TFs fused to the yeast Gal4 activation domain (AD) to 
generate diploid yeast containing both bait and prey. If the TF binds to the DNA-bait, the 
AD will induce reporter expression which can be measured by the conversion of the 
colorless X-gal to a blue compound (by the β–galactosidase enzyme encoded by LacZ), 
and by the ability of the yeast to grow on media lacking histidine even in the presence of 
3-amino-triazole (a competitive inhibitor of the His3 enzyme).  
Given that eY1H assays can be parallelized to study >1,000 TFs in a single 
experiment, this framework is particularly well suited to identify the sets of TFs that bind 
to a DNA region of interest (rather than the sets of DNA regions bound by a TFs as in 
ChIP-seq). In particular, eY1H assays (and other variations of the assay) have been 
used to identify the repertoire of TFs that bind to gene promoters and enhancers in 
humans, mice, nematodes, flies, and plants (1,21-26). Further, using eY1H assays, we 
determined altered TF binding to 109 SNVs associated with different genetic diseases 
including immune disorders, developmental malformations, cancer, and neurological 
disorders (1). This pipeline was based on PCR from human genomic DNA using wild 
type and mutated primers to generate the DNA-baits. As a consequence, the approach 
used was not suitable to clone and study indels (unless patient DNA samples are used) 
or novel DNA motifs from footprinting studies. In addition, the eY1H pipeline was not 
previously adapted to evaluate repetitive DNA elements given that the cloning steps 
were optimized for unique genomic DNA regions.  
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Here, we present two novel cloning approaches, one to study short DNA 
sequences (SNVs, indels, and novel DNA motifs), and another to study repetitive DNA 
elements. Using the former approach, we identified gain of TF binding to a two 
nucleotide substitution in the TERT promoter found in a patient with melanoma and to 
an 18 bp indel in a TAL1 super-enhancer found in a patient with T-cell acute 
lymphoblastic leukemia (27,28). In addition, we uncovered TFs that potentially bind to 
three novel motifs derived from genome-wide DNase I footprinting by the ENCODE 
Project that were previously uncharacterized (13). Finally, using the later eY1H 
approach to study repetitive DNA, we found 75 TFs that can bind to different Alu 
sequences present in the human genome. Overall, these eY1H-based approaches 
provide a novel toolkit to address genomic questions that have been challenging to 
address using current experimental and computational approaches.   
 
MATERIALS AND METHODS 
eY1H assays 
DNA-baits were generated using different approaches depending on the type of 
sequence cloned (Figure 1). Genomic variants (SNVs and indels) and novel DNA 
motifs were synthesized as oligonucleotides (Thermofisher) flanked by the attB4 and 
attB1R sequences for cloning using the Gateway recombination system (Figure 1 and 
Supplementary Table S1). Double-stranded oligonucleotides were generated by 
primer extension using Taq polymerase (Thermofisher) and a primer complementary to 
the attB1R (Supplementary Table S1) site using an initial denaturation step of 3 min at 
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95°C, ten cycles of 30 seconds at 55°C and 30 seconds at 72°C, followed by one cycle 
of 5 min at 72°C. The double-stranded oligonucleotides were then cloned into the 
pDONR-P4P1R by Gateway cloning using the BP Clonase II (ThermoFisher), and then 
transferred to the pMW#2 and pMW#3 vectors (Addgene) using the LR Clonase II 
(ThermoFisher), upstream of two reporter genes (HIS3 and LacZ). Both reporter 
constructs were integrated into the Y1HaS2 yeast strain genome by site-specific 
recombination to generate chromatinized DNA-bait strains as previously described 
(29,30).  
DNA-baits corresponding to repetitive DNA elements were generated by PCR 
using human genomic DNA (Clontech) as a template, Platinum Hifi Taq polymerase 
(ThermoFisher), and degenerate primers complementary to different family members of 
Alu elements (Alu-Fw  and Alu-Rv, Supplementary Table S1) or different variations of 
Alphoid DNA (Alphoid-Fw and Alphoid-Rv, Supplementary Table S1) (Figure 1). 
These primers include the attB4 and attB1R sequences for Gateway cloning. The PCR 
cycle involved an initial denaturation step of 2 min at 94°C, 35 cycles of 30 sec at 94°C, 
15 sec at 58°C, and 75 sec at 72°C, followed by a final extension for 7 min at 72°C.  
The random libraries containing the Alu sequences or the Alphoid DNA were cloned into 
the pDONR-P4P1R vector by Gateway cloning and transformed into DH5α bacteria. 
Individual colonies were picked and sequenced to identify the sequences cloned 
(Supplementary Table S2). Each sequence was then cloned using the Gateway 
system into the HIS3 and LacZ reporter vectors and integrated into the Y1HaS2 yeast 
strain genome. DNA-bait yeast strains were then sequenced to verify the identity of the 
yeast integrants. 
.CC-BY-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/459305doi: bioRxiv preprint first posted online Nov. 1, 2018; 
DNA-bait strains were mated with an array of yeast strains expressing 1,086 
human TF-preys using a Singer RoToR robotic platform, as previously described (1,19). 
Each interaction was tested in quadruplicate, and only interactions detected with at least 
two colonies were considered positive (Figure 1). As previously observed, ~90% of 
interactions were detected by all four replicates (1,19,23). 
 
Transient transfections and luciferase assays  
TF interactions with noncoding alleles were validated by luciferase assays in HEK293T 
cells. Given that testing the noncoding alleles in the short sequence context (20-40 bp) 
used in eY1H assays led to barely above background levels of luciferase activity (not 
shown), DNA-bait luciferase reporter clones were generated corresponding to the 500 
bp genomic sequence surrounding the noncoding alleles (Supplementary Table S3). 
Wild-type sequences were generated by PCR using human genomic DNA (Clontech) as 
a template, Platinum Hifi or SuperFi Taq polymerases (ThermoFisher), and primers 
surrounding the noncoding alleles. Mutant sequences were generated from the wild-
type sequence by PCR stitching using primers that contain the mutated nucleotide. 
DNA-bait luciferase reporter clones were generated by cloning the noncoding regions 
upstream of the firefly luciferase into a Gateway compatible vector generated from 
pGL4.23[luc2/minP] (1). TF-prey clones were generated by Gateway cloning the TF 
coding sequence into the pEZY3-VP160 vector (31).  
HEK293T cells were plated in 96-well opaque plates (~1 x 104 cells/well) 24 
hours prior to transfection in 100 µl DMEM + 10% FBS + 1% Antibiotic-Antimycotic 
100X. Cells were transfected with Lipofectamine 3000 (Invitrogen) according to the 
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manufacturer’s protocol using 20 ng of the DNA-bait pGL4.23[luc2/minP] luciferase 
reporter vector, 80 ng of the TF-pEZY3-VP160 vector, and 10 ng of renilla luciferase 
control vector. The empty pEZY3-VP160 vector co-transfected with the recombinant 
firefly luciferase plasmid was used as a normalization control. 48 hours after 
transfection, firefly and renilla luciferase activities were measured using the Dual-Glo 
Luciferase Assay System (Promega) according to the manufacturer’s protocol. Non-
transfected cells were used to subtract background luciferase activities, followed by 
normalizing firefly luciferase activity to renilla luciferase activity. 
 
ChIP-seq analysis 
ChIP-seq peaks for GATA4 (ENCSR590CNM) and ZBTB26 (ENCSR229DYF) were 
obtained from the ENCODE Project (32). A peak was assigned to a gene promoter if the 
midpoint of the peak was located within the -2kb to +250bp from the transcription start 
site (according to Gencode v19). In addition, promoter positions overlapping with coding 
regions were excluded from this analysis. The midpoint of peaks overlapping with 
promoter regions was calculated using the intersect option from BEDTools (33). The 
fraction of genes with GATA4 and ZBTB26 peaks in their promoters was calculated as a 
function of the number of UW.Motif.0118 and UW.Motif.0146 motifs, respectively.  
 
Prediction of DNA binding motif for zinc finger proteins  
DNA motif prediction for the Cys2-His2 zinc finger TFs ZBTB26 and ZNF646 was 
performed using an expanded support vector machine model available at 
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http://zf.princeton.edu/fingerSelect.php (34). For ZBTB26 zinc fingers 1-3 were used for 
predictions. For ZNF646 zinc fingers 1-3, 4-6, 11-13, 14-16, 20-22, and 23-25 were 
used for predictions. 
 
Co-expression between TFs and potential targets 
For each of the three DNA motifs derived from DNase I footprints tested by eY1H 
assays, potential target genes were determined by the presence of the DNA motifs 
within their promoter sequences. Promoter regions were considered between 2 kb 
upstream and 250 bp downstream of the transcription start sites. Alternative promoters 
were also considered. Co-expression between the TFs found to bind to the DNA motifs 
by eY1H assays and the genes containing different the motifs in their promoters was 
determined by calculating the Pearson correlation coefficient (PCC) between their 
expression levels across 32 tissues from the Expression Atlas 
(https://www.ebi.ac.uk/gxa/home, E-MTAB-2836). 
 
Gene ontology enrichment 
Biological Process Gene Ontology enrichment was determined using the Gene 
Ontology Consortium enrichment analysis tool using all human genes as background 
(http://geneontology.org/page/go-enrichment-analysis) for genes with at least two motifs 
in their promoter regions, for each of the DNA motifs derived from DNase I footprints. 
For each cluster of terms, only the term with the highest fold enrichment (>2) was 
considered. For each of the TFs found to bind to the DNA motifs in eY1H assays 
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(except ZBTB26 and ZNF646 for which no or few publications are available), the 
association between the TF and the gene ontology terms were annotated 
(Supplementary Table S4). 
 
RESULTS 
Identifying altered TF binding to noncoding SNVs and indels 
In our previous cloning strategy used to generate DNA-baits for identifying altered TF 
binding to noncoding variants by eY1H assays, DNA sequences were generated by 
PCR using human genomic DNA as a template and primers containing wild type or 
mutant sequences to introduce the allele variants (1). As a consequence, this cloning 
strategy presented several limitations for our current study: 1) the requirement of human 
DNA samples, 2) indels could not be successfully evaluated (unless genomic DNA was 
obtained from patient samples) as primers containing indels would fail to anneal to the 
wild type DNA template, and 3) the introduction of unwanted mutations during PCR 
even when using high fidelity polymerases, thus reducing the efficiency to generate 
DNA-baits without spurious mutations. To tackle these limitations, we modified our 
protocol to generate DNA-baits by using synthesized oligonucleotides containing a short 
sequence of interest (21 bp for SNVs, and 20 bp + indel length for indels) flanked by the 
attB4 and attB1R gateway cloning sites, followed by second strand synthesis using a 
universal primer complementary to the attB1R site (Figure 1).  
To determine whether this modified cloning approach coupled with eY1H assays 
can identify altered TF binding caused by variants associated with human disease, we 
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screened two noncoding somatic mutations found in cancer patients: a two-nucleotide 
substitution in the TERT promoter and a complex 18 bp indel in a super-enhancer of 
TAL1 (27,28). First, we tested the two-nucleotide substitution (GG AA) in the TERT 
promoter at position -138/-139. This particular mutation, derived from a patient with 
melanoma, was predicted to create an ETS/TCF binding site (28,35). Using eY1H 
assays against an array of 1,086 human TFs, we identified the binding of several ETS 
factors including GABPA, ELK1, ELK4, ETV1, ELF2, and ERF to the mutant AA allele 
but not to the wild-type GG allele, consistent with previous in silico predictions (Figure 
2A). Indeed, the -138/-139 GG AA mutation creates binding sites for these TFs 
(Figure 2B) but not for other ETS factors such as SPI1 and ETV7 that have slightly 
different DNA binding specificities (not shown). To validate the differential interactions 
observed, we performed luciferase assays by co-transfecting HEK293T cells with a 
plasmid carrying a 500 bp wild-type or mutant GG AA containing TERT promoter 
sequence driving luciferase expression and a plasmid expressing the indicated TFs 
fused to the VP160 (10 copies of VP16) activation domain. We found that GABPA, 
ELK1, ELK4, ETV1, and ERF lead to a stronger activation of the mutant promoter, 
whereas ELF2 did not induce reporter expression (Figure 2C). Interestingly, a previous 
study identified a gain of interaction with GABPA to two G A TERT promoter mutations 
at positions -124 and -146 (36). This suggests that binding sites for GABPA (and other 
ETS factors) created by single or di-nucleotide mutations at different positions in the 
TERT promoter may be responsible for TERT reactivation in tumors derived from 
different cancer patients. 
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In addition, we evaluated altered TF binding caused by an 18 bp insertion in a 
TAL1 super-enhancer found in a patient with T-cell acute lymphoblastic leukemia (27). 
We detected interactions involving ELK1, GABPA, ELF2, ELF3, and MYB with the 
insertion allele, but not with the wild type sequence or a sequence replacing the 
insertion with an (AT)9 repeat (Figure 3A). The interaction between MYB and the 
insertion allele was confirmed in human cells by luciferase assays (Figure 3B), 
consistent with a previous study that found that this particular insertion creates a binding 
site for MYB, further validating our approach (27). However, the eY1H interactions 
between the insertion allele and the ETS factors ELK1, GABPA, ELF2, and ELF3 could 
not be confirmed by luciferase assays (Figure 3B), even though these TFs are 
predicted to bind outside the indel (Figure 3C). This difference between eY1H assays 
(and motif predictions) and luciferase assays may be related to differences in chromatin 
context (i.e., eY1H assays test interactions within chromatinized DNA versus luciferase 
assays in episomal vectors) or differences in cellular context (i.e., interactions tested in 
yeast for eY1H assays versus human cells in luciferase assays). Additional experiments 
in the endogenous locus using genome edited cell lines will ultimately determine 
whether ETS factors affect gene expression caused by the insertion. Regardless of 
whether the interactions with ETS factors ultimately validate, it is important to note that 
eY1H assays narrowed down the follow-up studies to five candidate TFs compared to in 
silico analyses using default settings in CIS-BP (5) that led to predicting 30 losses and 
98 gains of interactions with the TAL1 super-enhancer insertion (not shown). This is 
particularly important, given that validation methods such as reporter assays, ChIP, and 
TF knockdowns are generally low-throughput. 
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Identifying TFs binding to novel DNA motifs 
Different experimental methods, including protein-binding microarrays, SELEX, bacterial 
one-hybrid assays, and ChIP-seq have identified DNA binding motifs for hundreds of 
human TFs (5,37,38). However, 289 (out of 683) DNA motifs identified by genome-wide 
footprinting using DNase I by the ENCODE Project (13) remain orphan (i.e., no TF has 
been predicted to bind these motifs). This can stem from the lack of DNA binding motifs 
for many human TFs (~50%), differences between DNA motifs determined in vitro and 
those occupied in vivo, from motif quality, and limitations in prediction algorithms. To 
determine whether eY1H assays can identify the TFs that bind to these orphan DNA 
motifs, we tested three of the DNA motifs identified by DNase I footprints by the 
ENCODE Project (13) that could not be matched to any human TF.  
Using eY1H assays, each DNA motif was tested using three tandem repeats and 
a mutated version of the motif as control (Figure 4A). For UW.Motif.0118 (GCTGATAA) 
we determined that GATA4, GATA5, and DMBX1 bind to the wild type but not the 
mutant DNA motif (Figure 4B). Indeed UW.Motif.0118 matches the DNA binding motifs 
for GATA4 and GATA5, which were reported by later publications (Figure 4C) (37,39). 
More importantly, we found that gene promoters that contain one or more instances of 
UW.Motif.0118 are enriched in ChIP-seq peaks for GATA4 (Figure 4H). DMBX1 can be 
discarded as a candidate to bind UW.Motif.0118 as its motif matches the junction 
between two motif copies in the tandem repeat rather than the motif itself (not shown). 
We also determined that UW.Motif.0146 (ATTTCTGG), but not the mutated motif, binds 
ZBTB26 (Figure 4D). The DNA binding motif for ZBTB26 has not yet been determined. 
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Using a position weight matrix prediction algorithm designed for cys2-his2 zinc finger 
TFs, we predicted a likely recognition motif based on the amino acid sequence of zinc 
fingers 1-3, which closely resembles UW.Motif.0146 (Figure 4E). Further, we found that 
gene promoters that contain one or more instances of UW.Motif.0146 are enriched in 
ChIP-seq peaks for ZBTB26, further validating our approach (Figure 4H). Finally, for 
UW.Motif.0167 (ACAAAAGA) we found that multiple SOX TFs and ZNF646 bind to the 
wild type but not the mutant motif in eY1H assays (Figure 4F). This DNA motif, partially 
matches SOX motifs (Figure 4G), while motifs are not available for ZNF646, a protein 
with 31 zinc fingers according to Uniprot. For several clusters of three ZNF646 zinc 
fingers, we predicted a CAAAA binding preference, a sequence present in 
UW.Motif.0167 (Supplementary Figure S1).  
To determine whether the TFs that bind to the orphan DNA motifs are 
functionally related to their potential respective target genes, we determined TF-target 
co-expression across tissues. We found that for motifs UW.Motif.0146 and 
UW.Motif.0167, the higher the occurrence of the motifs in target gene promoters the 
higher the correlation between the expression levels of the target genes and the TFs 
predicted to bind to those DNA motifs (Figure 4I). More importantly, we found that the 
Biological Process Gene Ontology terms associated with potential target genes that 
contain more than one instance of the motif in their promoter, are related to known 
functions of the TFs that bind the DNA motifs in eY1H assays (Supplementary Table 
S4). For example, genes that contain more than one instance of the UW.Motif.0118 in 
their promoters are associated with cardiovascular and neuronal development. This is 
consistent with the role of GATA4 and GATA5 in heart development and angiogenesis, 
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and the role of GATA4 in neuronal development and function (40-43). Similarly, genes 
that contain more than one instance of the UW.Motif.0167 in their promoters are 
associated with dendritic spine development, among other biological processes, as are 
SOX2, SOX5, and SOX11 (44-46). Altogether, this shows that our approach can identify 
the TFs that bind to uncharacterized motifs, including zinc fingers which are generally 
difficult to study, and that the TFs identified are functionally related to their potential 
target genes. 
 
TF binding to repetitive DNA elements 
The binding of TFs to repetitive DNA elements has been challenging to study 
experimentally given the difficulty of mapping sequencing reads derived from these 
elements to genomic locations (16,17). Indeed, most ChIP-seq pipelines currently 
remove a large fraction of the reads corresponding to repetitive elements (16). To 
illustrate the power of eY1H assays to identify TFs that bind to repetitive elements, we 
evaluated Alu sequences, a type of short interspaced nuclear element present in more 
than one million copies in the human genome. Studying TF binding to these sequences 
is particularly important given that Alu sequences are embedded within gene promoters, 
enhancers, and introns, and have been shown to play significant roles in gene 
regulation (18,47). In addition, these sequences are often silenced by mechanisms that 
are not fully understood which could in part be mediated by transcriptional repressors 
(48,49). 
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To evaluate TF binding to these repetitive elements, we cloned 20 Alu 
sequences into our eY1H pipeline (Supplementary Table S2). This was performed 
using degenerate primers complementary to the 5’ and 3’ ends of Alu sequences, which 
allowed us to obtain clones belonging to different Alu families, including the ancestral 
AluJ, the derived AluS, and the younger AluY elements. Using eY1H assays, we 
identified 75 TFs that bind to at least one Alu sequence, and 34 TFs that bind to at least 
20% of the 20 Alu sequences tested (Figure 5A and Supplementary Table S5). 
Interestingly, Alu sequences are enriched in binding to TFs belonging to the nuclear 
hormone receptor (NHR), zinc finger DHHC (ZF-DHHC), ETS, and regulatory factor X 
(RFX) families compared to the array of TFs tested (Figure 5B). Of note, we did not 
detect interactions with NHR or ZF-DHHC TFs for the two AluJ and a subset of AluS 
sequences tested, suggesting that binding sites for these TFs may have been acquired 
sometime during AluS divergence. Other than this, differences in TF binding between 
Alu sequences do not seem to cluster by Alu family, likely because of differences in 
deletions and truncations within family members. 
The widespread TF binding to Alu sequences observed is not a general feature of 
repetitive elements or of eY1H assays, as screening alphoid DNA (i.e., centromeric 
DNA sequences) only led to marginal TF binding (Figure 5C). Indeed, we did not 
identify any TFs that bound more than 20% of the 12 alphoid sequences tested (not 
shown), compared to 34 TFs for the Alu sequences. This is expected, as alphoid DNA is 
known to recruit multiple centromeric and heterochromatin proteins but not TFs (50). 
Altogether, we show that eY1H assays can identify TF binding to highly repetitive 
genomic sequences such as Alu sequences. Whether these TFs globally affect the 
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In this study we describe two approaches to evaluate TF binding to short DNA 
sequences (e.g., SNVs, indels, and novel DNA motifs) and repetitive elements. Testing 
these types of sequences has previously been challenging due to limitations in ChIP-
seq and DNA motif analyses. Indeed, motif analyses using CIS-BP (5) led to predicting 
128 and 56 differential TF interactions with the TAL1 super-enhancer insertion and the 
TERT -138/-139 GG AA mutation, respectively. Our approach greatly reduced the 
number of differential TFs that would need to validated, which is particularly important 
given that reporter assays, ChIP, and TF knockdowns followed by RT-qPCR are 
generally low-throughput. More importantly, it allows the identification of TF-DNA 
binding even in the absence of a priori TF candidates or human DNA template as in the 
case of novel DNA motifs identified by DNase I footprinting assays. The eY1H approach 
can also be applied to DNA motifs enriched in the regulatory regions of functionally 
related genes, in particular when these DNA motifs cannot be assigned to any TF. 
 Using eY1H assays we also evaluated 20 sequences belonging to different Alu 
families and identified 34 TFs that bind to at least 20% of the sequences tested. These 
TFs may be involved in regulating the expression of nearby genes or silencing Alu 
sequences. Alternatively, Alu sequences may also act as sinks for some TFs reducing 
their effective nuclear concentration. However, we did not detect a significantly higher 
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number of sequencing reads matching Alu sequences in ChIP-seq datasets from the 
ENCODE Project corresponding to Alu binding versus non-Alu binding TFs (not shown). 
This could be associated with epigenetic silencing of many Alu sequences which 
prevents TF binding in human cells in most tissues and conditions. Indeed, most Alu 
sequences have been found to be enriched in the H3K9me mark and to be actively 
silenced in somatic tissues (48,51). Nonetheless, thousands of Alu sequences in the 
human genome contain active histone marks and may be permissive for TF binding 
which could contribute to the transcriptional control of nearby genes in specific cells and 
conditions (18,52). For example, a recent study found that de novo ChIP-seq peaks for 
the H3K4me1 mark in macrophages infected with Mycobacterium tuberculosis contain 
Alu sequences enriched for binding sites of several TFs including ETS and NHR factors, 
consistent with our findings by eY1H assays (52). We anticipate that the approach we 
developed to study TF binding to Alu and alphoid sequences will shed light into the role 
of other repetitive elements in gene regulation, silencing, and establishment of 
heterochromatin.  
  Overall, the eY1H approaches described here unlock the possibility of 
characterizing altered TF binding to different types of genomic variants and studying the 
role of TFs in regulating the function of repetitive genomic elements.   
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FIGURE LEGENDS 
Figure 1. eY1H approaches to test short DNA sequences and repetitive DNA 
elements. Short DNA sequences are synthesized flanked by the attB4 and attB1R 
Gateway sites. The reverse strand is synthesized by primer extension (attB1R). The 
double stranded DNA generated is cloned into the pDONR-P4P1R vector by Gateway 
BP reaction. Repetitive DNA sequences are amplified from genomic DNA using 
degenerate primers flanked by the attB4 (forward) or the attB1R (reverse) sites. The 
repetitive element DNA library generated is cloned en masse into the pDONR-P4P1R 
vector and individual sequences are selected after bacterial transformation and picking 
of individual colonies. Both short DNA sequences and repetitive DNA are then 
transferred into eY1H reporter vectors (HIS3 and LacZ) and integrated into the yeast 
genome to generate DNA-baits strains. DNA-bait strains are tested for interactions 
against an array of 1,086 human TF-preys (TFs fused to the yeast Gal4 activation 
domain) by mating. Interactions are identified by the ability to grow in the absence of 
histidine and in the presence of the his3p inhibitor 3-Amino-1,2,4-triazole and turn blue 
in the presence of X-gal. Interactions are tested in quadruplicate. 
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 Figure 2. Identification of altered TF binding to a two-nucleotide substitution in 
the TERT promoter. (A) eY1H screen for wild type and a -138/-139 GG AA mutation 
in the TERT promoter associated with cancer. Each interaction was tested in 
quadruplicate. AD – empty vector control. (B) Motifs obtained from CIS-BP that match 
the differential TFs identified by eY1H assays. (C) Luciferase assays to validate the 
differential TF interactions with the TERT promoter alleles. HEK293T cells were co-
transfected with reporter plasmids containing the wild type or mutant TERT promoter 
region cloned upstream of the firefly luciferase reporter gene, and expression vectors 
for the indicated TFs (fused to the activation domain VP160). After 48 h, cells were 
harvested and luciferase assays were performed. Relative luciferase activity is plotted 
as fold change compared to cells co-transfected with the wild type TERT promoter 
construct and the VP160 vector control. A representative experiment of three is shown. 
The average of three replicates is indicated by the black line. *p<0.05 by one-tailed log-
transformed Student’s t-test with Benjamini-Hochberg correction. 
 
Figure 3. Identification of altered TF binding to a TAL1 super-enhancer insertion. 
(A) eY1H screen for an 18bp insertion in a TAL1 super-enhancer associated with T-cell 
acute lymphoblastic leukemia. Wild type and an (AT)9 sequence were screened as 
controls. Each interaction was tested in quadruplicate. AD – empty vector control. (B) 
Motifs obtained from CIS-BP that match the differential TFs identified by eY1H assays. 
(C) Luciferase assays to validate the differential TF interactions with the TAL1 super-
enhancer wild type and insertion alleles. HEK293T cells were co-transfected with 
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reporter plasmids containing the wild type or insertion TAL1 super-enhancer region 
cloned upstream of the firefly luciferase reporter gene, and expression vectors for the 
indicated TFs (fused to the activation domain VP160). After 48 h, cells were harvested 
and luciferase assays were performed. Relative luciferase activity is plotted as fold 
change compared to cells co-transfected with the wild type TAL1 super-enhancer 
construct and the VP160 vector control. A representative experiment of three is shown. 
The average of three replicates is indicated by the black line. *p<0.05 by one-tailed log-
transformed Student’s t-test with Benjamini-Hochberg correction. 
 
Figure 4. Identification of TFs that bind to novel DNA motifs. (A) Motifs were tested 
by eY1H assays as three tandem copies. Motifs with two mutated bases were tested as 
controls. (B, D, F) eY1H screen of three motifs identified by DNase I footprinting by the 
ENCODE Project. Tested sequences are indicated. Each interaction was tested in 
quadruplicate. AD – empty vector control. (C, G) Alignment of motif logos from CIS-BP 
to the tested sequences. (E) Predicted ZBTB26 motif based on the amino acid 
sequence of zinc fingers 1-3. (H) Fraction of genes with ChIP-seq peaks for GATA4 and 
ZBTB26 in their promoters as a function of the number of UW.Motif.0118 and 
UW.Motif.0146 motifs, respectively. *p<0.001 vs absence of motif by proportion 
comparison test. (I) Correlation between TF and target gene expression levels across 
32 tissues based on the occurrence of each motif in the target gene promoter. *p<0.001 
vs absence of motif by Mann-Whitey’s U test.  
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Figure 5. Identification of TFs that interact with Alu sequences. (A) TFs that 
interact with 20% or more of the Alu sequences tested by eY1H assays. TFs are 
ordered from top to bottom based on the number of Alu sequences they bind to. (B) 
Distribution by family for TFs that interact with at least 20% of the Alu sequences tested, 
compared to the distribution of TFs in the eY1H array. NHR – nuclear hormone 
receptor, ZF-DHHC – zinc finger DHHC, ZF-C2H2 – zinc finger cys2his2, HD – 
homeodomain, ETS – E26 transformation specific, HMG – high mobility group, RFX – 
regulatory factor X, bHLH – basic helix-loop-helix, bZIP – basic leucine zipper domain. 
*p<0.05 by proportion comparison test after Bonferroni correction. (C) Comparison 
between the number of PDIs detected for Alu and Alphoid sequences. Statistical 
significance determined by two-tailed Mann-Whitney’s U test. 
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